Evidence map›Paper›PMID 37241986›Full record

ArticleMolecules (Basel, Switzerland)2023

Cocrystallization of Progesterone with Nitrogen Heterocyclic Compounds: Synthesis, Characterization, Calculation and Property Evaluation.

Juan Xu, Wei Gao, Qi Zhang, Lifeng Ning

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Juan XuNHC Key Laboratory of Reproductive Health Engineering Technology Research, National Research Institute for Family Planning, Beijing 100081, China.
Wei GaoSchool of Pharmacy, Guangdong Pharmaceutical University, Guangzhou 510006, China.
Qi ZhangSchool of Chemistry and Chemical Engineering, Beijing Institute of Technology, Beijing 100081, China.
Lifeng NingNHC Key Laboratory of Reproductive Health Engineering Technology Research, National Research Institute for Family Planning, Beijing 100081, China.
National Health and Family Planning Commission · CNBeijing Institute of Technology · CNGuangdong Pharmaceutical University · CN

Funding

Innovation and Strengthening Project of Guangdong Pharmaceutical University-Special Project of Guangdong Education commission 2020KZDZX1128the Non-profit Central Research Institute Fund of National Research Institute For Family Planning 2022GJZ06
6 · The paper itself

Abstract

Progesterone injection is oily because of its poor solubility. It is necessary to develop new dosage forms or delivery methods for Progesterone. Six cocrystals of Progesterone with nitrogen heterocyclic compounds (2,6-diaminopyridine, isonicotinamide, 4-aminopyridine, aminopyrazine, picolinamide and pyrazinamide) have been designed and prepared by ethyl acetate-assisted grinding, of which four cocrystals (2,6-diaminopyridine, isonicotinamide, 4-aminopyridine and aminopyrazine) had single crystal data in 1:1 stoichiometry. Metadynamics-genetic crossing was used to search and optimize various cluster structures to explain the reason the other two cocrystals could not be obtained with suitable size for single crystal X-ray diffraction. In contrast to the carboxyl group, the amide group and amino group were good substituents in the pyridine/pyrazine ring for cocrystallization with Progesterone, which meant inductive effect played an important role in nitrogen heterocyclic compounds containing reactive hydrogen. All cocrystals were more soluble than Progesterone in water, and Progesterone-pyrazinamide cocystal featured the best water solubility performance with an approximately six-fold increase over free Progesterone. This successful attempt provides an effective route for designing and manufacturing novel solid states of Progesterone.

Indexed as

cocrystal particles with suitable sizemetadynamics-genetic crossingnitrogen heterocyclic compoundspharmaceutical cocrystalsprogesterone

Identifiers

PMID37241986
PMCPMC10224249
OpenAlexW4378085599

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.